According to the NEJM study, the risk of death reported in people taking Zithromax was more than double that of patients on amoxicillin, or those who took none. The highest risks were seen in Z-Pak users with pre-existing heart problems.
New York, New York (PRWEB) May 21, 2012
Parker Waichman LLP, a national law firm dedicated to protecting the legal rights of people injured by defective drugs, is investigating potential wrongful death lawsuit claims stemming from sudden, heart related deaths that might be associated with use of the antibiotic, Zithromax (azithromycin). On May 17, 2012, The New England Journal of Medicine (NEJM) published a study which found people using Zithromax, known popularly as Z-Pak, faced an increased risk of sudden cardiac death, compared to patients not treated with an antibiotic, as well as those taking alternative antibiotics. [nejm.org/doi/full/10.1056/NEJMoa1003833]
The NEJM study analyzed health records and data on millions of prescriptions for several antibiotics given to more than half a million Medicaid patients from 1992 to 2006. The risk of death reported in people taking Zithromax was more than double that of patients on amoxicillin, or those who took none. The highest risks were seen in Z-Pak users with pre-existing heart problems.
On May 18, the U.S. Food & Drug Administration (FDA) said in a statement it was reviewing the Zithromax study. The FDA's statement also pointed out that Zithromax belongs to a class of antibacterial drugs called macrolides, which have been associated with cardiovascular effects; specifically, prolongation of the QT interval. Prolongation of the QT interval can lead to torsades de pointes (TdP), an abnormal heart rhythm, which can be fatal, the agency said. [fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm304503.htm?utm_campaign=Google2&utm_source=fdaSearch&utm_medium=website&utm_term=zithromax&utm_content=1]
Zithromax is an antibiotic used to treat a number of bacterial infections, including respiratory infections, skin infections, ear infections and sexually transmitted diseases. While other antibiotics must be taken for at least 10 days, Z-Pak is only a 5-day course of treatment. The shorter treatment time has made Zithromax one of the more popular antibiotics on the market.
Parker Waichman LLP is offering free lawsuit evaluations to anyone who lost a loved one as a result of a sudden, heart related death that could be associated with use of Zithromax. Please contact their office by visiting the Zithromax Sudden Death page at http://www.yourlawyer.com. Free case evaluations are also available by calling 1 800 LAW INFO (1-800-529-4636).
For more information regarding Z-Pak lawsuits and Parker Waichman LLP, please visit http://www.yourlawyer.com or call 1-800-LAW-INFO (1-800-529-4636).
Parker Waichman LLP
Gary Falkowitz, Managing Attorney